Strategy

New Pharma Models for a new Healthcare Era

  • January, 10 2019
  • 42

When Google in November 2018 hired David Feinberg to head up its healthcare efforts, it was just the latest sign of the tech giant’s ambitions in the sector. Feinberg was previously president and CEO of Geisinger, among the US’ largest and most forward-lo

Company

Is January’s M&A a flash in the pan, or does it signal sustained dealmaking heat

  • January, 10 2019
  • 47

2019 started with a bang for pharma M&A: by January 7, $82 billion worth of shopping had been announced. Bristol Myers Squibb’s $74 billion cash and stock offer for Celgene on New Year’s day is the fourth-largest deal ever. It was followed days later